| GO:0003056 | regulation of vascular associated smooth muscle contraction | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0007362 | terminal region determination | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0008293 | torso signaling pathway | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0030878 | thyroid gland development | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0034111 | negative regulation of homotypic cell-cell adhesion | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0042386 | hemocyte differentiation | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0045500 | sevenless signaling pathway | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0048645 | animal organ formation | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0060020 | Bergmann glial cell differentiation | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0060440 | trachea formation | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 50.0% (1/2) | 13.25 | 0.000102 | 0.003436 |
| GO:0021697 | cerebellar cortex formation | 50.0% (1/2) | 12.67 | 0.000153 | 0.003767 |
| GO:0048708 | astrocyte differentiation | 50.0% (1/2) | 12.67 | 0.000153 | 0.003767 |
| GO:0060674 | placenta blood vessel development | 50.0% (1/2) | 12.67 | 0.000153 | 0.003767 |
| GO:0031134 | sister chromatid biorientation | 50.0% (1/2) | 12.67 | 0.000153 | 0.003767 |
| GO:0034508 | centromere complex assembly | 50.0% (1/2) | 12.67 | 0.000153 | 0.003767 |
| GO:0007346 | regulation of mitotic cell cycle | 100.0% (2/2) | 6.29 | 0.000164 | 0.003874 |
| GO:0005874 | microtubule | 100.0% (2/2) | 6.47 | 0.000128 | 0.003876 |
| GO:1901987 | regulation of cell cycle phase transition | 100.0% (2/2) | 6.49 | 0.000124 | 0.003942 |
| GO:0007173 | epidermal growth factor receptor signaling pathway | 50.0% (1/2) | 12.25 | 0.000205 | 0.003957 |
| GO:0019229 | regulation of vasoconstriction | 50.0% (1/2) | 12.25 | 0.000205 | 0.003957 |
| GO:0048313 | Golgi inheritance | 50.0% (1/2) | 12.25 | 0.000205 | 0.003957 |
| GO:1901988 | negative regulation of cell cycle phase transition | 100.0% (2/2) | 7.47 | 3.2e-05 | 0.004024 |
| GO:0099513 | polymeric cytoskeletal fiber | 100.0% (2/2) | 6.21 | 0.000182 | 0.00415 |
| GO:0045930 | negative regulation of mitotic cell cycle | 100.0% (2/2) | 7.6 | 2.7e-05 | 0.004239 |
| GO:0099081 | supramolecular polymer | 100.0% (2/2) | 6.14 | 0.000202 | 0.004295 |
| GO:0099512 | supramolecular fiber | 100.0% (2/2) | 6.14 | 0.000202 | 0.004295 |
| GO:0000075 | cell cycle checkpoint signaling | 100.0% (2/2) | 7.77 | 2.1e-05 | 0.004435 |
| GO:1901991 | negative regulation of mitotic cell cycle phase transition | 100.0% (2/2) | 7.77 | 2.1e-05 | 0.004435 |
| GO:0098696 | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 50.0% (1/2) | 11.93 | 0.000256 | 0.004534 |
| GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway | 50.0% (1/2) | 11.93 | 0.000256 | 0.004534 |
| GO:1903298 | negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway | 50.0% (1/2) | 11.93 | 0.000256 | 0.004534 |
| GO:1903046 | meiotic cell cycle process | 100.0% (2/2) | 5.93 | 0.000269 | 0.004644 |
| GO:0005078 | MAP-kinase scaffold activity | 50.0% (1/2) | 11.67 | 0.000307 | 0.004663 |
| GO:0006940 | regulation of smooth muscle contraction | 50.0% (1/2) | 11.67 | 0.000307 | 0.004663 |
| GO:0034110 | regulation of homotypic cell-cell adhesion | 50.0% (1/2) | 11.67 | 0.000307 | 0.004663 |
| GO:0038127 | ERBB signaling pathway | 50.0% (1/2) | 11.67 | 0.000307 | 0.004663 |
| GO:1903800 | positive regulation of miRNA maturation | 50.0% (1/2) | 11.67 | 0.000307 | 0.004663 |
| GO:0010564 | regulation of cell cycle process | 100.0% (2/2) | 5.71 | 0.000364 | 0.005045 |
| GO:0045933 | positive regulation of muscle contraction | 50.0% (1/2) | 11.45 | 0.000358 | 0.005078 |
| GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 50.0% (1/2) | 11.45 | 0.000358 | 0.005078 |
| GO:1903047 | mitotic cell cycle process | 100.0% (2/2) | 5.74 | 0.000347 | 0.005154 |
| GO:0055090 | acylglycerol homeostasis | 50.0% (1/2) | 11.25 | 0.000409 | 0.00544 |
| GO:0070328 | triglyceride homeostasis | 50.0% (1/2) | 11.25 | 0.000409 | 0.00544 |
| GO:0030810 | positive regulation of nucleotide biosynthetic process | 50.0% (1/2) | 10.8 | 0.000563 | 0.005524 |
| GO:0060324 | face development | 50.0% (1/2) | 10.8 | 0.000563 | 0.005524 |
| GO:1900038 | negative regulation of cellular response to hypoxia | 50.0% (1/2) | 10.8 | 0.000563 | 0.005524 |
| GO:1900373 | positive regulation of purine nucleotide biosynthetic process | 50.0% (1/2) | 10.8 | 0.000563 | 0.005524 |
| GO:2001171 | positive regulation of ATP biosynthetic process | 50.0% (1/2) | 10.8 | 0.000563 | 0.005524 |
| GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation | 50.0% (1/2) | 10.8 | 0.000563 | 0.005524 |
| GO:0007297 | ovarian follicle cell migration | 50.0% (1/2) | 10.93 | 0.000512 | 0.005532 |
| GO:0007298 | border follicle cell migration | 50.0% (1/2) | 10.93 | 0.000512 | 0.005532 |
| GO:0048679 | regulation of axon regeneration | 50.0% (1/2) | 10.93 | 0.000512 | 0.005532 |
| GO:0060446 | branching involved in open tracheal system development | 50.0% (1/2) | 10.93 | 0.000512 | 0.005532 |
| GO:0070570 | regulation of neuron projection regeneration | 50.0% (1/2) | 10.93 | 0.000512 | 0.005532 |
| GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA | 50.0% (1/2) | 10.93 | 0.000512 | 0.005532 |
| GO:0007430 | terminal branching, open tracheal system | 50.0% (1/2) | 11.08 | 0.00046 | 0.005543 |
| GO:0032839 | dendrite cytoplasm | 50.0% (1/2) | 11.08 | 0.00046 | 0.005543 |
| GO:0035591 | signaling adaptor activity | 50.0% (1/2) | 11.08 | 0.00046 | 0.005543 |
| GO:1902683 | regulation of receptor localization to synapse | 50.0% (1/2) | 11.08 | 0.00046 | 0.005543 |
| GO:1903798 | regulation of miRNA maturation | 50.0% (1/2) | 11.08 | 0.00046 | 0.005543 |
| GO:0010948 | negative regulation of cell cycle process | 100.0% (2/2) | 7.09 | 5.4e-05 | 0.005713 |
| GO:0050673 | epithelial cell proliferation | 50.0% (1/2) | 10.67 | 0.000614 | 0.00576 |
| GO:0060711 | labyrinthine layer development | 50.0% (1/2) | 10.67 | 0.000614 | 0.00576 |
| GO:0071481 | cellular response to X-ray | 50.0% (1/2) | 10.67 | 0.000614 | 0.00576 |
| GO:1901990 | regulation of mitotic cell cycle phase transition | 100.0% (2/2) | 6.85 | 7.5e-05 | 0.006016 |
| GO:0051754 | meiotic sister chromatid cohesion, centromeric | 50.0% (1/2) | 10.55 | 0.000665 | 0.006149 |
| GO:0099080 | supramolecular complex | 100.0% (2/2) | 5.25 | 0.00069 | 0.006286 |
| GO:0033314 | mitotic DNA replication checkpoint signaling | 50.0% (1/2) | 10.45 | 0.000716 | 0.006346 |
| GO:1902473 | regulation of protein localization to synapse | 50.0% (1/2) | 10.45 | 0.000716 | 0.006346 |
| GO:0004708 | MAP kinase kinase activity | 50.0% (1/2) | 10.25 | 0.000819 | 0.006528 |
| GO:0030216 | keratinocyte differentiation | 50.0% (1/2) | 10.25 | 0.000819 | 0.006528 |
| GO:0045981 | positive regulation of nucleotide metabolic process | 50.0% (1/2) | 10.25 | 0.000819 | 0.006528 |
| GO:0097746 | blood vessel diameter maintenance | 50.0% (1/2) | 10.25 | 0.000819 | 0.006528 |
| GO:1900544 | positive regulation of purine nucleotide metabolic process | 50.0% (1/2) | 10.25 | 0.000819 | 0.006528 |
| GO:0045786 | negative regulation of cell cycle | 100.0% (2/2) | 6.88 | 7.2e-05 | 0.006595 |
| GO:1903580 | positive regulation of ATP metabolic process | 50.0% (1/2) | 10.35 | 0.000767 | 0.006616 |
| GO:0070601 | centromeric sister chromatid cohesion | 50.0% (1/2) | 10.35 | 0.000767 | 0.006616 |
| GO:0008543 | fibroblast growth factor receptor signaling pathway | 50.0% (1/2) | 10.17 | 0.00087 | 0.006685 |
| GO:0010001 | glial cell differentiation | 50.0% (1/2) | 10.17 | 0.00087 | 0.006685 |
| GO:2001169 | regulation of ATP biosynthetic process | 50.0% (1/2) | 10.17 | 0.00087 | 0.006685 |
| GO:0051726 | regulation of cell cycle | 100.0% (2/2) | 5.15 | 0.000791 | 0.006731 |
| GO:0043539 | protein serine/threonine kinase activator activity | 50.0% (1/2) | 10.08 | 0.000921 | 0.006994 |
| GO:0010631 | epithelial cell migration | 50.0% (1/2) | 9.93 | 0.001023 | 0.007173 |
| GO:0035296 | regulation of tube diameter | 50.0% (1/2) | 9.93 | 0.001023 | 0.007173 |
| GO:0034501 | protein localization to kinetochore | 50.0% (1/2) | 9.93 | 0.001023 | 0.007173 |
| GO:1903083 | protein localization to condensed chromosome | 50.0% (1/2) | 9.93 | 0.001023 | 0.007173 |
| GO:0046579 | positive regulation of Ras protein signal transduction | 50.0% (1/2) | 10.01 | 0.000972 | 0.00721 |
| GO:0051057 | positive regulation of small GTPase mediated signal transduction | 50.0% (1/2) | 10.01 | 0.000972 | 0.00721 |
| GO:0008286 | insulin receptor signaling pathway | 50.0% (1/2) | 9.73 | 0.001177 | 0.007359 |
| GO:0030165 | PDZ domain binding | 50.0% (1/2) | 9.73 | 0.001177 | 0.007359 |
| GO:0035150 | regulation of tube size | 50.0% (1/2) | 9.73 | 0.001177 | 0.007359 |
| GO:0043406 | positive regulation of MAP kinase activity | 50.0% (1/2) | 9.73 | 0.001177 | 0.007359 |
| GO:2000637 | positive regulation of miRNA-mediated gene silencing | 50.0% (1/2) | 9.73 | 0.001177 | 0.007359 |
| GO:0044732 | mitotic spindle pole body | 50.0% (1/2) | 9.73 | 0.001177 | 0.007359 |
| GO:0071459 | protein localization to chromosome, centromeric region | 50.0% (1/2) | 9.73 | 0.001177 | 0.007359 |
| GO:0000779 | condensed chromosome, centromeric region | 50.0% (1/2) | 9.86 | 0.001074 | 0.007369 |
| GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 50.0% (1/2) | 9.86 | 0.001074 | 0.007369 |
| GO:0009953 | dorsal/ventral pattern formation | 50.0% (1/2) | 9.67 | 0.001228 | 0.007389 |
| GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 50.0% (1/2) | 9.67 | 0.001228 | 0.007389 |
| GO:0097110 | scaffold protein binding | 50.0% (1/2) | 9.67 | 0.001228 | 0.007389 |
| GO:0035556 | intracellular signal transduction | 100.0% (2/2) | 4.98 | 0.001009 | 0.007398 |
| GO:0004674 | protein serine/threonine kinase activity | 100.0% (2/2) | 4.85 | 0.001199 | 0.007427 |
| GO:0030808 | regulation of nucleotide biosynthetic process | 50.0% (1/2) | 9.8 | 0.001125 | 0.007558 |
| GO:1900371 | regulation of purine nucleotide biosynthetic process | 50.0% (1/2) | 9.8 | 0.001125 | 0.007558 |
| GO:0000076 | DNA replication checkpoint signaling | 50.0% (1/2) | 9.45 | 0.001432 | 0.007877 |
| GO:0004707 | MAP kinase activity | 50.0% (1/2) | 9.45 | 0.001432 | 0.007877 |
| GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 50.0% (1/2) | 9.45 | 0.001432 | 0.007877 |
| GO:0022408 | negative regulation of cell-cell adhesion | 50.0% (1/2) | 9.45 | 0.001432 | 0.007877 |
| GO:0048754 | branching morphogenesis of an epithelial tube | 50.0% (1/2) | 9.45 | 0.001432 | 0.007877 |
| GO:0051177 | meiotic sister chromatid cohesion | 50.0% (1/2) | 9.45 | 0.001432 | 0.007877 |
| GO:0047496 | vesicle transport along microtubule | 50.0% (1/2) | 9.4 | 0.001483 | 0.007952 |
| GO:0048308 | organelle inheritance | 50.0% (1/2) | 9.4 | 0.001483 | 0.007952 |
| GO:0004714 | transmembrane receptor protein tyrosine kinase activity | 50.0% (1/2) | 9.3 | 0.001586 | 0.007965 |
| GO:0009875 | pollen-pistil interaction | 50.0% (1/2) | 9.3 | 0.001586 | 0.007965 |
| GO:0051019 | mitogen-activated protein kinase binding | 50.0% (1/2) | 9.3 | 0.001586 | 0.007965 |
| GO:0061138 | morphogenesis of a branching epithelium | 50.0% (1/2) | 9.3 | 0.001586 | 0.007965 |
| GO:0090398 | cellular senescence | 50.0% (1/2) | 9.3 | 0.001586 | 0.007965 |
| GO:0120111 | neuron projection cytoplasm | 50.0% (1/2) | 9.3 | 0.001586 | 0.007965 |
| GO:0022402 | cell cycle process | 100.0% (2/2) | 4.71 | 0.001464 | 0.007982 |
| GO:0048538 | thymus development | 50.0% (1/2) | 9.5 | 0.001381 | 0.00801 |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 50.0% (1/2) | 9.5 | 0.001381 | 0.00801 |
| GO:1900037 | regulation of cellular response to hypoxia | 50.0% (1/2) | 9.5 | 0.001381 | 0.00801 |
| GO:1903034 | regulation of response to wounding | 50.0% (1/2) | 9.5 | 0.001381 | 0.00801 |
| GO:0006468 | protein phosphorylation | 100.0% (2/2) | 4.64 | 0.001614 | 0.008047 |
| GO:0001667 | ameboidal-type cell migration | 50.0% (1/2) | 9.35 | 0.001534 | 0.008091 |
| GO:0072697 | protein localization to cell cortex | 50.0% (1/2) | 9.35 | 0.001534 | 0.008091 |
| GO:1900370 | positive regulation of post-transcriptional gene silencing by RNA | 50.0% (1/2) | 9.25 | 0.001637 | 0.008095 |
| GO:0009866 | induced systemic resistance, ethylene mediated signaling pathway | 50.0% (1/2) | 9.21 | 0.001688 | 0.00822 |
| GO:0060964 | regulation of miRNA-mediated gene silencing | 50.0% (1/2) | 9.21 | 0.001688 | 0.00822 |
| GO:0007094 | mitotic spindle assembly checkpoint signaling | 50.0% (1/2) | 9.17 | 0.001739 | 0.008405 |
| GO:0007093 | mitotic cell cycle checkpoint signaling | 100.0% (2/2) | 8.08 | 1.3e-05 | 0.008599 |
| GO:0008104 | protein localization | 100.0% (2/2) | 4.55 | 0.00182 | 0.00873 |
| GO:0032401 | establishment of melanosome localization | 50.0% (1/2) | 8.93 | 0.002046 | 0.008759 |
| GO:0032402 | melanosome transport | 50.0% (1/2) | 8.93 | 0.002046 | 0.008759 |
| GO:0051904 | pigment granule transport | 50.0% (1/2) | 8.93 | 0.002046 | 0.008759 |
| GO:0051905 | establishment of pigment granule localization | 50.0% (1/2) | 8.93 | 0.002046 | 0.008759 |
| GO:0033046 | negative regulation of sister chromatid segregation | 50.0% (1/2) | 8.93 | 0.002046 | 0.008759 |
| GO:0033048 | negative regulation of mitotic sister chromatid segregation | 50.0% (1/2) | 8.93 | 0.002046 | 0.008759 |
| GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 50.0% (1/2) | 8.93 | 0.002046 | 0.008759 |
| GO:2000816 | negative regulation of mitotic sister chromatid separation | 50.0% (1/2) | 8.93 | 0.002046 | 0.008759 |
| GO:0071173 | spindle assembly checkpoint signaling | 50.0% (1/2) | 9.08 | 0.001841 | 0.008766 |
| GO:0010165 | response to X-ray | 50.0% (1/2) | 8.83 | 0.002199 | 0.008768 |
| GO:0031152 | aggregation involved in sorocarp development | 50.0% (1/2) | 8.83 | 0.002199 | 0.008768 |
| GO:1900368 | regulation of post-transcriptional gene silencing by RNA | 50.0% (1/2) | 8.83 | 0.002199 | 0.008768 |
| GO:0045839 | negative regulation of mitotic nuclear division | 50.0% (1/2) | 8.83 | 0.002199 | 0.008768 |
| GO:0032400 | melanosome localization | 50.0% (1/2) | 8.86 | 0.002148 | 0.008784 |
| GO:0051875 | pigment granule localization | 50.0% (1/2) | 8.86 | 0.002148 | 0.008784 |
| GO:0005816 | spindle pole body | 50.0% (1/2) | 8.86 | 0.002148 | 0.008784 |
| GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 50.0% (1/2) | 8.86 | 0.002148 | 0.008784 |
| GO:1905819 | negative regulation of chromosome separation | 50.0% (1/2) | 8.86 | 0.002148 | 0.008784 |
| GO:0001568 | blood vessel development | 50.0% (1/2) | 9.04 | 0.001892 | 0.008812 |
| GO:0007112 | male meiosis cytokinesis | 50.0% (1/2) | 9.04 | 0.001892 | 0.008812 |
| GO:0071174 | mitotic spindle checkpoint signaling | 50.0% (1/2) | 9.04 | 0.001892 | 0.008812 |
| GO:0070727 | cellular macromolecule localization | 100.0% (2/2) | 4.4 | 0.002256 | 0.00883 |
| GO:0042461 | photoreceptor cell development | 50.0% (1/2) | 9.01 | 0.001943 | 0.008856 |
| GO:0060148 | positive regulation of post-transcriptional gene silencing | 50.0% (1/2) | 9.01 | 0.001943 | 0.008856 |
| GO:0008608 | attachment of spindle microtubules to kinetochore | 50.0% (1/2) | 9.01 | 0.001943 | 0.008856 |
| GO:0043327 | chemotaxis to cAMP | 50.0% (1/2) | 8.9 | 0.002097 | 0.008859 |
| GO:0007162 | negative regulation of cell adhesion | 50.0% (1/2) | 8.8 | 0.00225 | 0.008861 |
| GO:0099518 | vesicle cytoskeletal trafficking | 50.0% (1/2) | 8.8 | 0.00225 | 0.008861 |
| GO:0004672 | protein kinase activity | 100.0% (2/2) | 4.45 | 0.002089 | 0.008885 |
| GO:0032838 | plasma membrane bounded cell projection cytoplasm | 50.0% (1/2) | 8.76 | 0.002301 | 0.008898 |
| GO:0051985 | negative regulation of chromosome segregation | 50.0% (1/2) | 8.76 | 0.002301 | 0.008898 |
| GO:0031577 | spindle checkpoint signaling | 50.0% (1/2) | 8.97 | 0.001995 | 0.009025 |
| GO:0018107 | peptidyl-threonine phosphorylation | 50.0% (1/2) | 8.67 | 0.002455 | 0.009212 |
| GO:0018210 | peptidyl-threonine modification | 50.0% (1/2) | 8.67 | 0.002455 | 0.009212 |
| GO:0044818 | mitotic G2/M transition checkpoint | 50.0% (1/2) | 8.67 | 0.002455 | 0.009212 |
| GO:0070372 | regulation of ERK1 and ERK2 cascade | 50.0% (1/2) | 8.67 | 0.002455 | 0.009212 |
| GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 100.0% (2/2) | 4.33 | 0.002488 | 0.009281 |
| GO:0016310 | phosphorylation | 100.0% (2/2) | 4.34 | 0.002427 | 0.009327 |
| GO:0071902 | positive regulation of protein serine/threonine kinase activity | 50.0% (1/2) | 8.58 | 0.002608 | 0.009673 |
| GO:0050772 | positive regulation of axonogenesis | 50.0% (1/2) | 8.53 | 0.00271 | 0.009994 |
| GO:0030295 | protein kinase activator activity | 50.0% (1/2) | 8.5 | 0.002761 | 0.010124 |
| GO:0009898 | cytoplasmic side of plasma membrane | 50.0% (1/2) | 8.47 | 0.002812 | 0.010194 |
| GO:0033036 | macromolecule localization | 100.0% (2/2) | 4.24 | 0.002806 | 0.01023 |
| GO:0060147 | regulation of post-transcriptional gene silencing | 50.0% (1/2) | 8.45 | 0.002863 | 0.010321 |
| GO:0016301 | kinase activity | 100.0% (2/2) | 4.21 | 0.002926 | 0.010431 |
| GO:0019209 | kinase activator activity | 50.0% (1/2) | 8.42 | 0.002914 | 0.010446 |
| GO:0033206 | meiotic cytokinesis | 50.0% (1/2) | 8.4 | 0.002965 | 0.010453 |
| GO:0043204 | perikaryon | 50.0% (1/2) | 8.4 | 0.002965 | 0.010453 |
| GO:0033047 | regulation of mitotic sister chromatid segregation | 50.0% (1/2) | 8.37 | 0.003017 | 0.010517 |
| GO:0051784 | negative regulation of nuclear division | 50.0% (1/2) | 8.37 | 0.003017 | 0.010517 |
| GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 50.0% (1/2) | 8.35 | 0.003068 | 0.010637 |
| GO:1903578 | regulation of ATP metabolic process | 50.0% (1/2) | 8.32 | 0.003119 | 0.010756 |
| GO:0072384 | organelle transport along microtubule | 50.0% (1/2) | 8.28 | 0.003221 | 0.011048 |
| GO:0006937 | regulation of muscle contraction | 50.0% (1/2) | 8.25 | 0.003272 | 0.011163 |
| GO:0051128 | regulation of cellular component organization | 100.0% (2/2) | 4.11 | 0.003365 | 0.01142 |
| GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 50.0% (1/2) | 8.19 | 0.003425 | 0.011441 |
| GO:1900542 | regulation of purine nucleotide metabolic process | 50.0% (1/2) | 8.19 | 0.003425 | 0.011441 |
| GO:1902750 | negative regulation of cell cycle G2/M phase transition | 50.0% (1/2) | 8.19 | 0.003425 | 0.011441 |
| GO:0051641 | cellular localization | 100.0% (2/2) | 4.08 | 0.003488 | 0.01153 |
| GO:0034502 | protein localization to chromosome | 50.0% (1/2) | 8.17 | 0.003476 | 0.011552 |
| GO:0031252 | cell leading edge | 50.0% (1/2) | 8.1 | 0.00363 | 0.011578 |
| GO:0036289 | peptidyl-serine autophosphorylation | 50.0% (1/2) | 8.1 | 0.00363 | 0.011578 |
| GO:0007062 | sister chromatid cohesion | 50.0% (1/2) | 8.1 | 0.00363 | 0.011578 |
| GO:0043405 | regulation of MAP kinase activity | 50.0% (1/2) | 8.13 | 0.003579 | 0.011589 |
| GO:0000775 | chromosome, centromeric region | 50.0% (1/2) | 8.13 | 0.003579 | 0.011589 |
| GO:0071479 | cellular response to ionizing radiation | 50.0% (1/2) | 8.15 | 0.003527 | 0.0116 |
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | 100.0% (2/2) | 4.06 | 0.003573 | 0.011691 |
| GO:0044773 | mitotic DNA damage checkpoint signaling | 50.0% (1/2) | 8.06 | 0.003732 | 0.011845 |
| GO:0006140 | regulation of nucleotide metabolic process | 50.0% (1/2) | 8.03 | 0.003834 | 0.012109 |
| GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 50.0% (1/2) | 7.99 | 0.003936 | 0.01219 |
| GO:0060966 | regulation of gene silencing by RNA | 50.0% (1/2) | 7.99 | 0.003936 | 0.01219 |
| GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 50.0% (1/2) | 7.99 | 0.003936 | 0.01219 |
| GO:0043547 | positive regulation of GTPase activity | 50.0% (1/2) | 8.01 | 0.003885 | 0.01221 |
| GO:0051384 | response to glucocorticoid | 50.0% (1/2) | 7.91 | 0.00414 | 0.012761 |
| GO:0050770 | regulation of axonogenesis | 50.0% (1/2) | 7.9 | 0.004191 | 0.012856 |
| GO:0047485 | protein N-terminus binding | 50.0% (1/2) | 7.88 | 0.004242 | 0.01295 |
| GO:0022407 | regulation of cell-cell adhesion | 50.0% (1/2) | 7.86 | 0.004293 | 0.013044 |
| GO:0009864 | induced systemic resistance, jasmonic acid mediated signaling pathway | 50.0% (1/2) | 7.85 | 0.004344 | 0.013074 |
| GO:0044774 | mitotic DNA integrity checkpoint signaling | 50.0% (1/2) | 7.85 | 0.004344 | 0.013074 |
| GO:0007507 | heart development | 50.0% (1/2) | 7.81 | 0.004447 | 0.013319 |
| GO:0018108 | peptidyl-tyrosine phosphorylation | 50.0% (1/2) | 7.8 | 0.004498 | 0.013347 |
| GO:0018212 | peptidyl-tyrosine modification | 50.0% (1/2) | 7.8 | 0.004498 | 0.013347 |
| GO:0099568 | cytoplasmic region | 50.0% (1/2) | 7.78 | 0.004549 | 0.013374 |
| GO:0030071 | regulation of mitotic metaphase/anaphase transition | 50.0% (1/2) | 7.78 | 0.004549 | 0.013374 |
| GO:0031960 | response to corticosteroid | 50.0% (1/2) | 7.76 | 0.0046 | 0.0134 |
| GO:0034243 | regulation of transcription elongation by RNA polymerase II | 50.0% (1/2) | 7.76 | 0.0046 | 0.0134 |
| GO:0032786 | positive regulation of DNA-templated transcription, elongation | 50.0% (1/2) | 7.75 | 0.004651 | 0.013487 |
| GO:1903522 | regulation of blood circulation | 50.0% (1/2) | 7.72 | 0.004753 | 0.013721 |
| GO:0010965 | regulation of mitotic sister chromatid separation | 50.0% (1/2) | 7.68 | 0.004855 | 0.01389 |
| GO:2001251 | negative regulation of chromosome organization | 50.0% (1/2) | 7.68 | 0.004855 | 0.01389 |
| GO:0046578 | regulation of Ras protein signal transduction | 50.0% (1/2) | 7.67 | 0.004906 | 0.013973 |
| GO:0000077 | DNA damage checkpoint signaling | 50.0% (1/2) | 7.63 | 0.005059 | 0.014157 |
| GO:0007167 | enzyme-linked receptor protein signaling pathway | 50.0% (1/2) | 7.63 | 0.005059 | 0.014157 |
| GO:0051056 | regulation of small GTPase mediated signal transduction | 50.0% (1/2) | 7.63 | 0.005059 | 0.014157 |
| GO:0051650 | establishment of vesicle localization | 50.0% (1/2) | 7.63 | 0.005059 | 0.014157 |
| GO:0051648 | vesicle localization | 50.0% (1/2) | 7.61 | 0.00511 | 0.014237 |
| GO:0004712 | protein serine/threonine/tyrosine kinase activity | 50.0% (1/2) | 7.6 | 0.005161 | 0.014255 |
| GO:0009913 | epidermal cell differentiation | 50.0% (1/2) | 7.6 | 0.005161 | 0.014255 |
| GO:0090257 | regulation of muscle system process | 50.0% (1/2) | 7.55 | 0.005314 | 0.014552 |
| GO:1904375 | regulation of protein localization to cell periphery | 50.0% (1/2) | 7.55 | 0.005314 | 0.014552 |
| GO:0048666 | neuron development | 50.0% (1/2) | 7.53 | 0.005416 | 0.014768 |
| GO:0070192 | chromosome organization involved in meiotic cell cycle | 50.0% (1/2) | 7.49 | 0.005569 | 0.015056 |
| GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 50.0% (1/2) | 7.49 | 0.005569 | 0.015056 |
| GO:0042770 | signal transduction in response to DNA damage | 50.0% (1/2) | 7.47 | 0.00562 | 0.01513 |
| GO:0032784 | regulation of DNA-templated transcription elongation | 50.0% (1/2) | 7.46 | 0.005672 | 0.015203 |
| GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 50.0% (1/2) | 7.43 | 0.005774 | 0.015412 |
| GO:0010508 | positive regulation of autophagy | 50.0% (1/2) | 7.42 | 0.005825 | 0.015419 |
| GO:0033045 | regulation of sister chromatid segregation | 50.0% (1/2) | 7.42 | 0.005825 | 0.015419 |
| GO:0000793 | condensed chromosome | 50.0% (1/2) | 7.41 | 0.005876 | 0.01549 |
| GO:1905818 | regulation of chromosome separation | 50.0% (1/2) | 7.38 | 0.005978 | 0.015694 |
| GO:0006996 | organelle organization | 100.0% (2/2) | 3.68 | 0.006079 | 0.015894 |
| GO:0010970 | transport along microtubule | 50.0% (1/2) | 7.35 | 0.006131 | 0.015965 |
| GO:0031570 | DNA integrity checkpoint signaling | 50.0% (1/2) | 7.34 | 0.006182 | 0.016032 |
| GO:0045860 | positive regulation of protein kinase activity | 50.0% (1/2) | 7.31 | 0.006284 | 0.016231 |
| GO:0050769 | positive regulation of neurogenesis | 50.0% (1/2) | 7.3 | 0.006335 | 0.016231 |
| GO:0080027 | response to herbivore | 50.0% (1/2) | 7.3 | 0.006335 | 0.016231 |
| GO:2001234 | negative regulation of apoptotic signaling pathway | 50.0% (1/2) | 7.29 | 0.006386 | 0.016296 |
| GO:1905475 | regulation of protein localization to membrane | 50.0% (1/2) | 7.27 | 0.006488 | 0.016491 |
| GO:0043087 | regulation of GTPase activity | 50.0% (1/2) | 7.24 | 0.00659 | 0.016552 |
| GO:0005876 | spindle microtubule | 50.0% (1/2) | 7.24 | 0.00659 | 0.016552 |
| GO:0042593 | glucose homeostasis | 50.0% (1/2) | 7.25 | 0.006539 | 0.016554 |
| GO:0065004 | protein-DNA complex assembly | 50.0% (1/2) | 7.23 | 0.006641 | 0.016615 |
| GO:0043130 | ubiquitin binding | 50.0% (1/2) | 7.21 | 0.006743 | 0.016804 |
| GO:0099111 | microtubule-based transport | 50.0% (1/2) | 7.2 | 0.006794 | 0.016865 |
| GO:0035239 | tube morphogenesis | 50.0% (1/2) | 7.17 | 0.006947 | 0.017112 |
| GO:0051983 | regulation of chromosome segregation | 50.0% (1/2) | 7.17 | 0.006947 | 0.017112 |
| GO:0006796 | phosphate-containing compound metabolic process | 100.0% (2/2) | 3.57 | 0.007113 | 0.017254 |
| GO:0033674 | positive regulation of kinase activity | 50.0% (1/2) | 7.13 | 0.007151 | 0.017281 |
| GO:0001763 | morphogenesis of a branching structure | 50.0% (1/2) | 7.14 | 0.0071 | 0.017288 |
| GO:0051962 | positive regulation of nervous system development | 50.0% (1/2) | 7.14 | 0.0071 | 0.017288 |
| GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 50.0% (1/2) | 7.15 | 0.007049 | 0.017296 |
| GO:0007088 | regulation of mitotic nuclear division | 50.0% (1/2) | 7.11 | 0.007202 | 0.017338 |
| GO:1902749 | regulation of cell cycle G2/M phase transition | 50.0% (1/2) | 7.09 | 0.007304 | 0.017517 |
| GO:0006793 | phosphorus metabolic process | 100.0% (2/2) | 3.54 | 0.007361 | 0.017589 |
| GO:0030705 | cytoskeleton-dependent intracellular transport | 50.0% (1/2) | 7.07 | 0.007405 | 0.017629 |
| GO:0009631 | cold acclimation | 50.0% (1/2) | 7.06 | 0.007456 | 0.017685 |
| GO:0031267 | small GTPase binding | 50.0% (1/2) | 7.05 | 0.007507 | 0.01774 |
| GO:0048534 | hematopoietic or lymphoid organ development | 50.0% (1/2) | 7.04 | 0.007558 | 0.017794 |
| GO:0032182 | ubiquitin-like protein binding | 50.0% (1/2) | 7.02 | 0.007711 | 0.018088 |
| GO:0033500 | carbohydrate homeostasis | 50.0% (1/2) | 7.01 | 0.007762 | 0.01814 |
| GO:0048545 | response to steroid hormone | 50.0% (1/2) | 7.0 | 0.007813 | 0.018193 |
| GO:0008022 | protein C-terminus binding | 50.0% (1/2) | 6.97 | 0.007966 | 0.018481 |
| GO:0009880 | embryonic pattern specification | 50.0% (1/2) | 6.94 | 0.008119 | 0.018566 |
| GO:0030855 | epithelial cell differentiation | 50.0% (1/2) | 6.94 | 0.008119 | 0.018566 |
| GO:0007030 | Golgi organization | 50.0% (1/2) | 6.95 | 0.008068 | 0.018583 |
| GO:0019887 | protein kinase regulator activity | 50.0% (1/2) | 6.95 | 0.008068 | 0.018583 |
| GO:0010212 | response to ionizing radiation | 50.0% (1/2) | 6.93 | 0.00817 | 0.018616 |
| GO:0098562 | cytoplasmic side of membrane | 50.0% (1/2) | 6.92 | 0.008221 | 0.018665 |
| GO:0008340 | determination of adult lifespan | 50.0% (1/2) | 6.91 | 0.008272 | 0.018714 |
| GO:0019207 | kinase regulator activity | 50.0% (1/2) | 6.9 | 0.008374 | 0.018878 |
| GO:0002009 | morphogenesis of an epithelium | 50.0% (1/2) | 6.85 | 0.008629 | 0.019384 |
| GO:0061640 | cytoskeleton-dependent cytokinesis | 50.0% (1/2) | 6.85 | 0.00868 | 0.01943 |
| GO:0005737 | cytoplasm | 100.0% (2/2) | 3.41 | 0.008818 | 0.019671 |
| GO:0030155 | regulation of cell adhesion | 50.0% (1/2) | 6.81 | 0.008883 | 0.019748 |
| GO:0014069 | postsynaptic density | 50.0% (1/2) | 6.8 | 0.008985 | 0.019767 |
| GO:0071900 | regulation of protein serine/threonine kinase activity | 50.0% (1/2) | 6.8 | 0.008985 | 0.019767 |
| GO:0099572 | postsynaptic specialization | 50.0% (1/2) | 6.8 | 0.008985 | 0.019767 |
| GO:0010720 | positive regulation of cell development | 50.0% (1/2) | 6.75 | 0.009291 | 0.02023 |
| GO:0051020 | GTPase binding | 50.0% (1/2) | 6.75 | 0.009291 | 0.02023 |
| GO:2001233 | regulation of apoptotic signaling pathway | 50.0% (1/2) | 6.75 | 0.009291 | 0.02023 |
| GO:0030424 | axon | 50.0% (1/2) | 6.74 | 0.009342 | 0.020272 |
| GO:0030335 | positive regulation of cell migration | 50.0% (1/2) | 6.72 | 0.009444 | 0.020355 |
| GO:0043410 | positive regulation of MAPK cascade | 50.0% (1/2) | 6.72 | 0.009444 | 0.020355 |
| GO:0050767 | regulation of neurogenesis | 50.0% (1/2) | 6.71 | 0.009545 | 0.020436 |
| GO:2000147 | positive regulation of cell motility | 50.0% (1/2) | 6.71 | 0.009545 | 0.020436 |
| GO:0044057 | regulation of system process | 50.0% (1/2) | 6.68 | 0.009749 | 0.020733 |
| GO:0051345 | positive regulation of hydrolase activity | 50.0% (1/2) | 6.68 | 0.009749 | 0.020733 |
| GO:0031346 | positive regulation of cell projection organization | 50.0% (1/2) | 6.66 | 0.009851 | 0.02088 |
| GO:0008283 | cell population proliferation | 50.0% (1/2) | 6.64 | 0.010004 | 0.021064 |
| GO:0071824 | protein-DNA complex subunit organization | 50.0% (1/2) | 6.64 | 0.010004 | 0.021064 |
| GO:0098978 | glutamatergic synapse | 50.0% (1/2) | 6.59 | 0.01036 | 0.021253 |
| GO:0005635 | nuclear envelope | 50.0% (1/2) | 6.6 | 0.010309 | 0.021285 |
| GO:0048732 | gland development | 50.0% (1/2) | 6.6 | 0.010309 | 0.021285 |
| GO:0051783 | regulation of nuclear division | 50.0% (1/2) | 6.6 | 0.010309 | 0.021285 |
| GO:0036211 | protein modification process | 100.0% (2/2) | 3.3 | 0.010355 | 0.021311 |
| GO:0000166 | nucleotide binding | 100.0% (2/2) | 3.3 | 0.010308 | 0.021492 |
| GO:1901265 | nucleoside phosphate binding | 100.0% (2/2) | 3.3 | 0.010308 | 0.021492 |
| GO:0002252 | immune effector process | 50.0% (1/2) | 6.57 | 0.010513 | 0.021497 |
| GO:0048729 | tissue morphogenesis | 50.0% (1/2) | 6.6 | 0.010258 | 0.021529 |
| GO:0003018 | vascular process in circulatory system | 50.0% (1/2) | 6.55 | 0.010614 | 0.021567 |
| GO:0040017 | positive regulation of locomotion | 50.0% (1/2) | 6.55 | 0.010614 | 0.021567 |
| GO:0140096 | catalytic activity, acting on a protein | 100.0% (2/2) | 3.27 | 0.01068 | 0.021632 |
| GO:0007165 | signal transduction | 100.0% (2/2) | 3.26 | 0.010866 | 0.021938 |
| GO:0051960 | regulation of nervous system development | 50.0% (1/2) | 6.49 | 0.011123 | 0.022387 |
| GO:0016477 | cell migration | 50.0% (1/2) | 6.47 | 0.011276 | 0.022623 |
| GO:1990778 | protein localization to cell periphery | 50.0% (1/2) | 6.44 | 0.011479 | 0.022959 |
| GO:0018105 | peptidyl-serine phosphorylation | 50.0% (1/2) | 6.38 | 0.011937 | 0.023726 |
| GO:0030674 | protein-macromolecule adaptor activity | 50.0% (1/2) | 6.38 | 0.011937 | 0.023726 |
| GO:0003013 | circulatory system process | 50.0% (1/2) | 6.38 | 0.011988 | 0.023753 |
| GO:0001934 | positive regulation of protein phosphorylation | 50.0% (1/2) | 6.35 | 0.012192 | 0.02386 |
| GO:0051347 | positive regulation of transferase activity | 50.0% (1/2) | 6.35 | 0.012192 | 0.02386 |
| GO:0010506 | regulation of autophagy | 50.0% (1/2) | 6.37 | 0.01209 | 0.02388 |
| GO:0010975 | regulation of neuron projection development | 50.0% (1/2) | 6.36 | 0.012141 | 0.023907 |
| GO:0007018 | microtubule-based movement | 50.0% (1/2) | 6.33 | 0.012395 | 0.024036 |
| GO:0018209 | peptidyl-serine modification | 50.0% (1/2) | 6.33 | 0.012395 | 0.024036 |
| GO:0099120 | socially cooperative development | 50.0% (1/2) | 6.34 | 0.012344 | 0.024084 |
| GO:0005938 | cell cortex | 50.0% (1/2) | 6.31 | 0.012598 | 0.024137 |
| GO:0036094 | small molecule binding | 100.0% (2/2) | 3.16 | 0.012571 | 0.024157 |
| GO:0002229 | defense response to oomycetes | 50.0% (1/2) | 6.31 | 0.012548 | 0.024185 |
| GO:0048523 | negative regulation of cellular process | 100.0% (2/2) | 3.16 | 0.012542 | 0.024248 |
| GO:0009873 | ethylene-activated signaling pathway | 50.0% (1/2) | 6.28 | 0.012802 | 0.024454 |
| GO:0004713 | protein tyrosine kinase activity | 50.0% (1/2) | 6.28 | 0.012853 | 0.024477 |
| GO:0048870 | cell motility | 50.0% (1/2) | 6.22 | 0.013361 | 0.02537 |
| GO:0000910 | cytokinesis | 50.0% (1/2) | 6.22 | 0.013412 | 0.025391 |
| GO:0010639 | negative regulation of organelle organization | 50.0% (1/2) | 6.2 | 0.013513 | 0.025507 |
| GO:0042327 | positive regulation of phosphorylation | 50.0% (1/2) | 6.2 | 0.013564 | 0.025528 |
| GO:0019199 | transmembrane receptor protein kinase activity | 50.0% (1/2) | 6.16 | 0.013971 | 0.026216 |
| GO:0098552 | side of membrane | 50.0% (1/2) | 6.14 | 0.014123 | 0.026424 |
| GO:0060284 | regulation of cell development | 50.0% (1/2) | 6.14 | 0.014174 | 0.026441 |
| GO:0060090 | molecular adaptor activity | 50.0% (1/2) | 6.13 | 0.014276 | 0.026553 |
| GO:0043408 | regulation of MAPK cascade | 50.0% (1/2) | 6.11 | 0.014377 | 0.026587 |
| GO:0043412 | macromolecule modification | 100.0% (2/2) | 3.06 | 0.014339 | 0.026593 |
| GO:0062013 | positive regulation of small molecule metabolic process | 50.0% (1/2) | 6.1 | 0.014479 | 0.026621 |
| GO:0098687 | chromosomal region | 50.0% (1/2) | 6.1 | 0.014479 | 0.026621 |
| GO:0009524 | phragmoplast | 50.0% (1/2) | 6.09 | 0.014631 | 0.026824 |
| GO:0045859 | regulation of protein kinase activity | 50.0% (1/2) | 6.08 | 0.014682 | 0.02684 |
| GO:0008047 | enzyme activator activity | 50.0% (1/2) | 6.04 | 0.01519 | 0.02761 |
| GO:0033044 | regulation of chromosome organization | 50.0% (1/2) | 6.04 | 0.01519 | 0.02761 |
| GO:0030334 | regulation of cell migration | 50.0% (1/2) | 6.03 | 0.015291 | 0.027715 |
| GO:0000160 | phosphorelay signal transduction system | 50.0% (1/2) | 6.02 | 0.015393 | 0.02782 |
| GO:0010311 | lateral root formation | 50.0% (1/2) | 6.01 | 0.015494 | 0.027925 |
| GO:0060918 | auxin transport | 50.0% (1/2) | 6.0 | 0.015545 | 0.027937 |
| GO:2000145 | regulation of cell motility | 50.0% (1/2) | 6.0 | 0.015596 | 0.02795 |
| GO:0051607 | defense response to virus | 50.0% (1/2) | 5.99 | 0.015697 | 0.027975 |
| GO:0140546 | defense response to symbiont | 50.0% (1/2) | 5.99 | 0.015697 | 0.027975 |
| GO:0055088 | lipid homeostasis | 50.0% (1/2) | 5.98 | 0.015748 | 0.027987 |
| GO:0043549 | regulation of kinase activity | 50.0% (1/2) | 5.96 | 0.016002 | 0.028281 |
| GO:0120035 | regulation of plasma membrane bounded cell projection organization | 50.0% (1/2) | 5.96 | 0.016002 | 0.028281 |
| GO:0010562 | positive regulation of phosphorus metabolic process | 50.0% (1/2) | 5.94 | 0.016256 | 0.028571 |
| GO:0045937 | positive regulation of phosphate metabolic process | 50.0% (1/2) | 5.94 | 0.016256 | 0.028571 |
| GO:0008285 | negative regulation of cell population proliferation | 50.0% (1/2) | 5.92 | 0.016459 | 0.028848 |
| GO:0031344 | regulation of cell projection organization | 50.0% (1/2) | 5.91 | 0.01656 | 0.028946 |
| GO:0006935 | chemotaxis | 50.0% (1/2) | 5.91 | 0.016611 | 0.028956 |
| GO:0090066 | regulation of anatomical structure size | 50.0% (1/2) | 5.89 | 0.016763 | 0.029141 |
| GO:0051703 | biological process involved in intraspecies interaction between organisms | 50.0% (1/2) | 5.83 | 0.017473 | 0.030293 |
| GO:0042330 | taxis | 50.0% (1/2) | 5.83 | 0.017524 | 0.030299 |
| GO:0051179 | localization | 100.0% (2/2) | 2.9 | 0.017845 | 0.03077 |
| GO:0019538 | protein metabolic process | 100.0% (2/2) | 2.89 | 0.018099 | 0.031124 |
| GO:0009867 | jasmonic acid mediated signaling pathway | 50.0% (1/2) | 5.75 | 0.018538 | 0.031794 |
| GO:0004888 | transmembrane signaling receptor activity | 50.0% (1/2) | 5.73 | 0.01869 | 0.031969 |
| GO:0002218 | activation of innate immune response | 50.0% (1/2) | 5.69 | 0.019248 | 0.032834 |
| GO:0040012 | regulation of locomotion | 50.0% (1/2) | 5.68 | 0.01945 | 0.033092 |
| GO:0040011 | locomotion | 50.0% (1/2) | 5.62 | 0.020261 | 0.034288 |
| GO:0051656 | establishment of organelle localization | 50.0% (1/2) | 5.62 | 0.02021 | 0.034293 |
| GO:0042542 | response to hydrogen peroxide | 50.0% (1/2) | 5.59 | 0.020615 | 0.034795 |
| GO:0009914 | hormone transport | 50.0% (1/2) | 5.57 | 0.020919 | 0.035215 |
| GO:0045597 | positive regulation of cell differentiation | 50.0% (1/2) | 5.55 | 0.021274 | 0.035717 |
| GO:1902532 | negative regulation of intracellular signal transduction | 50.0% (1/2) | 5.51 | 0.02178 | 0.036471 |
| GO:0009738 | abscisic acid-activated signaling pathway | 50.0% (1/2) | 5.51 | 0.021881 | 0.036545 |
| GO:1902533 | positive regulation of intracellular signal transduction | 50.0% (1/2) | 5.48 | 0.022286 | 0.037123 |
| GO:0031331 | positive regulation of cellular catabolic process | 50.0% (1/2) | 5.46 | 0.022589 | 0.037531 |
| GO:0016740 | transferase activity | 100.0% (2/2) | 2.73 | 0.022726 | 0.03766 |
| GO:0002239 | response to oomycetes | 50.0% (1/2) | 5.45 | 0.022792 | 0.037671 |
| GO:0043066 | negative regulation of apoptotic process | 50.0% (1/2) | 5.44 | 0.022943 | 0.037824 |
| GO:0002253 | activation of immune response | 50.0% (1/2) | 5.41 | 0.023348 | 0.038195 |
| GO:0051129 | negative regulation of cellular component organization | 50.0% (1/2) | 5.41 | 0.023348 | 0.038195 |
| GO:0106310 | protein serine kinase activity | 50.0% (1/2) | 5.41 | 0.023449 | 0.038262 |
| GO:0051336 | regulation of hydrolase activity | 50.0% (1/2) | 5.42 | 0.023297 | 0.038308 |
| GO:0005815 | microtubule organizing center | 50.0% (1/2) | 5.4 | 0.023601 | 0.038314 |
| GO:0048519 | negative regulation of biological process | 100.0% (2/2) | 2.7 | 0.023543 | 0.038318 |
| GO:0048471 | perinuclear region of cytoplasm | 50.0% (1/2) | 5.36 | 0.024207 | 0.039001 |
| GO:0051338 | regulation of transferase activity | 50.0% (1/2) | 5.36 | 0.024207 | 0.039001 |
| GO:0010051 | xylem and phloem pattern formation | 50.0% (1/2) | 5.37 | 0.024106 | 0.039035 |
| GO:0007166 | cell surface receptor signaling pathway | 50.0% (1/2) | 5.31 | 0.024965 | 0.040121 |
| GO:0001932 | regulation of protein phosphorylation | 50.0% (1/2) | 5.31 | 0.025117 | 0.040263 |
| GO:0043085 | positive regulation of catalytic activity | 50.0% (1/2) | 5.29 | 0.025471 | 0.040727 |
| GO:0051276 | chromosome organization | 50.0% (1/2) | 5.28 | 0.025622 | 0.040867 |
| GO:0002237 | response to molecule of bacterial origin | 50.0% (1/2) | 5.27 | 0.025824 | 0.041087 |
| GO:0045089 | positive regulation of innate immune response | 50.0% (1/2) | 5.25 | 0.026178 | 0.041442 |
| GO:0009615 | response to virus | 50.0% (1/2) | 5.25 | 0.026127 | 0.041465 |
| GO:0071478 | cellular response to radiation | 50.0% (1/2) | 5.22 | 0.026733 | 0.042113 |
| GO:0016043 | cellular component organization | 100.0% (2/2) | 2.61 | 0.026671 | 0.042119 |
| GO:0045202 | synapse | 50.0% (1/2) | 5.21 | 0.026834 | 0.042167 |
| GO:0043069 | negative regulation of programmed cell death | 50.0% (1/2) | 5.19 | 0.027187 | 0.042618 |
| GO:0043005 | neuron projection | 50.0% (1/2) | 5.18 | 0.027439 | 0.042908 |
| GO:0051640 | organelle localization | 50.0% (1/2) | 5.17 | 0.02754 | 0.04296 |
| GO:1905393 | plant organ formation | 50.0% (1/2) | 5.16 | 0.027692 | 0.043091 |
| GO:0009896 | positive regulation of catabolic process | 50.0% (1/2) | 5.16 | 0.027793 | 0.043143 |
| GO:0005694 | chromosome | 50.0% (1/2) | 5.1 | 0.028852 | 0.044678 |
| GO:0042325 | regulation of phosphorylation | 50.0% (1/2) | 5.09 | 0.029054 | 0.044882 |
| GO:0019901 | protein kinase binding | 50.0% (1/2) | 5.07 | 0.029507 | 0.045472 |
| GO:0048518 | positive regulation of biological process | 100.0% (2/2) | 2.53 | 0.029835 | 0.045647 |
| GO:0031401 | positive regulation of protein modification process | 50.0% (1/2) | 5.06 | 0.029709 | 0.045673 |
| GO:0032880 | regulation of protein localization | 50.0% (1/2) | 5.06 | 0.02981 | 0.045718 |
| GO:0071840 | cellular component organization or biogenesis | 100.0% (2/2) | 2.52 | 0.030234 | 0.046147 |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 50.0% (1/2) | 5.02 | 0.030616 | 0.046618 |
| GO:0022414 | reproductive process | 100.0% (2/2) | 2.51 | 0.030977 | 0.047055 |
| GO:0019904 | protein domain specific binding | 50.0% (1/2) | 4.98 | 0.031472 | 0.047694 |
| GO:0032501 | multicellular organismal process | 100.0% (2/2) | 2.47 | 0.032398 | 0.04898 |
| GO:0060548 | negative regulation of cell death | 50.0% (1/2) | 4.91 | 0.032882 | 0.049594 |